NPM1mut AML often co-occurs with mutations in the epigenetic modifiers TET2 and DNMT3A. These genes are known drivers of clonal hematopoiesis, a condition associated with an elevated relative risk of progression to myeloid malignancy in older adults [59]. This evidence concerns the gene DNMT3A and myeloid neoplasm.